Suppr超能文献

口服免疫治疗的初始加量阶段可改善食物过敏儿童父母的生活质量和心理负担。

Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy.

机构信息

From the Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Allergy Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Allergy Asthma Proc. 2024 Mar 1;45(2):128-136. doi: 10.2500/aap.2024.45.240001.

Abstract

Oral immunotherapy (OIT) can impose psychological burdens on patients and their parents due to the necessary preparations and repeated adverse reactions. To investigate changes in quality of life (QoL) and psychological burden in parents of children receiving OIT for food allergy (FA). Children aged 3-13 years with FA were enrolled. Parents were asked to fill out the Korean versions of the Food Allergy Quality of Life-Parental Burden (FAQL-PB), the Korean versions of the Food Allergy Quality of Life-Parental Form (K-FAQLQ-PF), the Korean versions of the Beck Anxiety Inventory (K-BAI), and the Korean version of the Patient Health Questionnaire-9 (PHQ-9) for depression before OIT (T1), after 2 months of updosing (T2), and after the end of the updosing phase (T3). A total of 111 parents were enrolled. The total FAQL-PB scores were decreased at T2 and T3 compared with those at T1 (all p < 0.001). Greater improvement in the total FAQL-PB score at T2 was noted in parents with a higher parental burden (FAQL-PB score ≥ 74 points) at baseline than in those with a lower parental burden (p = 0.001). Among the K-FAQLQ-PF domains, "food anxiety" scores were decreased at T2 and T3 compared with those at T1 (p = 0.049 and p = 0.030, respectively), whereas there was no change in "social and dietary limitation" and "emotional impact" scores between T1 and T2 and between T1 and T3. However, no differences were observed in K-BAI and PHQ-9 scores between T1 and T2 and between T1 and T3. Our results suggest that OIT improves parental burden and QoL in parents of children with FA.

摘要

口服免疫疗法 (OIT) 可能会给患者及其父母带来心理负担,因为需要进行必要的准备并反复出现不良反应。本研究旨在调查食物过敏 (FA) 患儿接受 OIT 治疗后父母生活质量 (QoL) 和心理负担的变化。纳入年龄为 3-13 岁的 FA 患儿。父母需要填写食物过敏生活质量-父母负担问卷 (FAQL-PB)、食物过敏生活质量-父母问卷 (K-FAQLQ-PF)、贝克焦虑量表 (K-BAI) 和患者健康问卷-9 (PHQ-9) 的韩文版,分别于 OIT 前 (T1)、增量 2 个月后 (T2) 和增量结束后 (T3)。共纳入 111 名父母。与 T1 相比,T2 和 T3 的总 FAQL-PB 评分均降低 (均 p < 0.001)。与低负担组相比,基线时 FAQL-PB 评分较高 (≥74 分) 的父母在 T2 时的总 FAQL-PB 评分改善更明显 (p = 0.001)。在 K-FAQLQ-PF 各领域中,“食物焦虑”评分在 T2 和 T3 时均低于 T1 (分别为 p = 0.049 和 p = 0.030),而“社会和饮食限制”和“情绪影响”评分在 T1 与 T2 之间以及 T1 与 T3 之间均无变化。然而,T1 与 T2 之间以及 T1 与 T3 之间的 K-BAI 和 PHQ-9 评分无差异。我们的结果表明,OIT 可改善 FA 患儿父母的负担和 QoL。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验